6 Results for "

J9

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "J9" in MCE Product Catalog:

14
14 Cited Publications
Cat. No.: HY-15194
CAS No.: 52328-98-0
Purity:  98.06%
Synonyms: ASC-J9; GO-Y025
Dimethylcurcumin (ASC-J9) is an androgen receptor degradation enhancer that effectively suppresses castration resistant prostate cancer cell proliferation and invasion.
loading...
    loading...
Cat. No.: HY-160758
CAS No.: 1414864-34-8
Target:  

Insecticide

Research Areas:  

Others

J9Z38 is a metabolite of Cyantraniliprole (HY-12779), a broad-spectrum agrochemical insecticide belonging to the anthranilic diamide insecticide class. Cyantraniliprole effectively controls the growth of various pests on fruits, vegetables, cereals and other crops. Thus, J9Z38 is a key indicator for indirect detection and evaluation of Cyantraniliprole residue levels .
loading...
    loading...
Cat. No.: HY-112255
CAS No.: 947018-15-7
Research Areas:  

Cancer

J9 is a small molecule that reverses Dexamethasone (HY-14648) resistance in T-cell acute lymphoblastic leukemia. J9 is lethal to CUTLL1 cells only in the presence of Dexamethasone. J9 inhibits CUTLL1 cell growth with an EC50 of 28 μM in combination with Dexamethasone .
loading...
    loading...
Cat. No.: HY-176421
CAS No.: 3070438-85-3
Target:  

PROTACs PI3K

Research Areas:  

Cancer

PROTAC PI3K/110β degrader-1 (J-9) is a PROTAC based PI3K/110β degrader (Red: PI3K/110β inhibitor (HY-75124), black: linker, Blue: E3 ligase ligand) .
loading...
    loading...
Cat. No.: HY-15194R
CAS No.: 52328-98-0
Synonyms: ASC-J9 (Standard); GO-Y025 (Standard)
Dimethylcurcumin (Standard) is the analytical standard of Dimethylcurcumin. This product is intended for research and analytical applications. Dimethylcurcumin (ASC-J9) is an androgen receptor degradation enhancer that effectively suppresses castration resistant prostate cancer cell proliferation and invasion.
loading...
    loading...
Cat. No.: HY-162358
Research Areas:  

Infection

DHFR-IN-17 (compound j9) is an oral active SaDHFR inhibitor with the IC50 of 0.97 nM. DHFR-IN-17 shows antibacterial activity against S. aureus with the minimum inhibitory concentration of 0.031 μg/mL .
loading...
    loading...